Recognition and treatment of posttraumatic stress disorder

JAMA

Volumn 286, Issue 5, 2001, Pages 584-588

  Davidson, J R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLONIDINE; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

HUMAN; NOTE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE;

EID: 0035413878     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.5.584     Document Type: Note

References (70)

1. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: A randomized controlled trial
2. Longitudinal study of psychiatric symptoms, disability, mortality, and emigration among Bosnian refugees
3. Lifetime events and posttraumatic stress disorder in 4 postconflict settings
4. Posttraumatic stress disorder in the National Comorbidity Survey
5. Traumatic events and posttraumatic stress disorder in the community: Prevalence, risk factors and comorbidity
6. Posttraumatic stress disorder: The burden to the individual and to society
7. Post-traumatic stress disorder in the community: An epidemiological study
8. Diseases among men 20 years after exposure to severe stress: Implications for clinical research and medical care
9. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults
10. The economic burden of anxiety disorders in the 1990s
11. Functional impairment and utilization of services associated with posttraumatic stress in the community
12. Traumatic experiences in psychiatric outpatients
13. Posttraumatic stress disorder and service utilization among urban mental center clients
14. Post-traumatic stress disorder in primary care settings: Prevalence and physicians' detection
15. Posttraumatic stress disorder in the primary care medical setting
16. Selected symptoms associated with sexual and physical abuse history among female patients with gastrointestinal disorders: The impact on subsequent healthcare visits
17. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome
18. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: A preliminary model
19. Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder
20. Recognizing and treating post-traumatic stress disorder
21. Domestic violence: What to ask, what to do
22. Health-related quality of life in primary care patients with mental disorders: Results from the PRIME-MD 1000 study
23. A proposed algorithm for improved recognition and treatment of the depression/anxiety spectrum in primary care
24. Short screening scale for DSM-IV posttraumatic stress disorder
25. Derivation of the SPAN: A brief diagnostic screening test for PTSD
26. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety
27. Treatment of posttraumatic stress disorder with amitriptyline and placebo
28. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine
29. Fluoxetine in posttraumatic stress disorder
30. Fluoxetine in post-traumatic stress disorder: Randomized double-blind study
31. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial
32. Multicenter, double-blind comparisons of sertraline and placebo in the treatment of posttraumatic stress disorder
33. Sertraline treatment of posttraumatic disorder: Results of 24 weeks of open-label continuation treatment
34. Response characteristics to antidepressants and placebo in post-traumatic stress disorder
35. Pharmacotherapy of posttraumatic stress disorder: Treatment options, long-term follow-up and predictors of outcome
36. Expert Consensus Guideline Series: Treatment of posttraumatic stress disorder
37. An open trial of paroxetine in patients with non-combat-related, chronic posttraumatic stress disorder
38. Open trial of citalopram in adults with posttraumatic stress disorder
39. Fluvoxamine in civilians with posttraumatic stress disorder
40. Nefazodone in posttraumatic stress disorder: Results from six open-label trials
41. Trial of trazodone for post-traumatic stress disorder using a multiple baseline group design
42. Bupropion treatment in veterans with posttraumatic stress disorder: An open study
43. A pilot study of mirtazapine in post-traumatic stress disorder
44. Propranolol and clonidine in the treatment of post-traumatic stress disorders of war
45. Buspirone in combat-related posttraumatic stress disorder
46. Inositol treatment of PTSD
47. Carbamazepine in posttraumatic stress disorder: A preliminary evaluation
48. Valproate in combat-related posttraumatic stress disorder
49. Lamotrigine vs placebo for the treatment of posttraumatic stress disorder
50. A preliminary study of olanzapine in the treatment of post-traumatic stress disorder
51. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment
52. Treatment of recent trauma survivors with benzodiazepines: A prospective study
53. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat induced posttraumatic stress disorder
54. Posttraumatic stress disorder: Psychological factors and psychosocial intervention
55. Pilot evaluation of hypnotic medication during acute traumatic stress response
56. Sertaline and posttraumatic stress disorder: Results of 24 weeks of open-label sertraline followed by a 28-week discontinuation study
57. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring
58. The efficacy of exposure therapy, stress inoculation training and their combination in ameliorating PTSD for female victims of assault
59. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder
60. The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder
61. Randomized controlled trial comparing problem-solving treatment with amitriptyline and placebo in primary care
62. The treatment of social phobia in general practice: Is exposure therapy feasible?
63. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis
64. Psychological debriefing
65. Treatment of children and adolescents
66. Introduction